Valuation Jade Biosciences, Inc.

Stocks

Real-time Estimate Cboe BZX Other stock markets 20:29:58 30/07/2026 +04			5-day change	1st Jan Change
19.85 ^USD	+2.58%		+1.53%	+29.10%

07-02	Jade Biosciences to Receive up to $22 Million as Part of Licensing Deal With Paragon Therapeutics	MT
06-29	Jade Biosciences, Inc.(NasdaqCM:JBIO) added to Russell Microcap Growth Benchmark Index	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2025	2026	2027	2028
Market Cap ¹	709.8	1,149	-	-
Change	-	61.81%	-	-
Enterprise Value (EV) ¹	373.7	895.1	848.3	818.8
Change	-	139.53%	-5.22%	-3.48%
P/E	-4.84x	-7.44x	-7.51x	-7.55x
PBR	-	4.56x	8.72x	5.25x
PEG	-0.2x	0.4x	7.97x	15.74x
Capitalization / Revenue	-	-	-	-
EV / Revenue	-	-	-	-
EV / EBITDA	-	-4.72x	-4.32x	-4.03x
EV / EBIT	-3.29x	-4.96x	-4.33x	-3.71x
EV / FCF	-3.94x	-5.61x	-4.86x	-4.01x
FCF Yield	-25.4%	-17.8%	-20.6%	-24.9%
Dividend per Share ²	-	-	-	-
Rate of return	-	-	-	-
EPS ²	-3.19	-2.601	-2.577	-2.564
Distribution rate	-	-	-	-
Net sales ¹	-	-	-	-
EBITDA ¹	-	-189.7	-196.2	-203
EBIT ¹	-113.5	-180.3	-196	-220.7
Net income ¹	-127.4	-173.2	-191.2	-218.4
Net Debt ¹	-336.2	-253.5	-300.3	-329.8
Reference price ²	15.43	19.35	19.35	19.35
Nbr of stocks (in thousands)	46,004	59,360	-	-
Announcement Date	06/03/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
JADE BIOSCIENCES, INC.	-7.44x	-	-4.72x	-	1.15B
LONZA GROUP AG	33.57x	6.03x	17.92x	0.96%	48.95B
IQVIA HOLDINGS INC.	32.11x	3.13x	13.52x	-.--%	40.75B
REVOLUTION MEDICINES, INC.	-22.58x	337.47x	-20.61x	-.--%	38.46B
BEONE MEDICINES AG	48.6x	4.95x	32.02x	-.--%	36.38B
CELLTRION, INC.	27.45x	7.94x	19.96x	0.42%	28.45B
MEDPACE HOLDINGS, INC.	33.26x	5.44x	24.73x	-.--%	16.33B
ICON PUBLIC LIMITED COMPANY	25.19x	1.99x	12.05x	-.--%	13.65B
EUROFINS SCIENTIFIC SE	22.83x	2x	8.66x	1.16%	13.56B
Average	21.44x	46.12x	11.50x	0.32%	26.41B
Weighted average by Cap.	24.49x	58.99x	12.82x	0.32%